No price history for this company yet.
Ownership & Control
Latest available filings- Controlling entity
- Privately held (no public ownership data)
- Insiders
- —
- Institutions
- —
- Free float
- —
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →- Pierre Fabre Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease - PR Newswire2026-10-14
- Atara, Pierre Fabre take third shot at FDA approval of Ebvallo - BioWorld News2026-10-01
- Laboratoires Pierre Fabre Appoints Nicolas Zombré CEO - Beauty Packaging2026-08-26
